Newsletter
FDA Calendar
Market Data
Heat Map
Screener
Insider Trades
LOGIN
|
REGISTER
Index
Newsroom
Featured Stocks
Free Daily Newsletter
Stock Lists
See All Health Stock Lists
Biotechnology Stocks
Pharmaceutical Stocks
Big Pharma Stocks
Healthcare Stocks
Medical Stocks
Diagnostics & Research Stocks
Medical Device Stocks
Biotechnology News
Pharmaceutical News
Medical News
Healthcare News
Register
FDA Calendar
Market Data
Stock Screener
Insider Trades
Search
Logout
Index
Newsroom
Featured Stocks
Stock Lists
Biotech
Pharma
Medical
Healthcare
Watch List
Recent Insider Transactions - Regeneron Pharmaceuticals (NASDAQ: REGN)
Follow
NASDAQ:REGN
Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ
REGN
Regeneron Pharmaceuticals
Van Plew Daniel P
/
officer: EVP & General Mgr, Industrial
12/16/2024
Sell
$730.81
969
$708K
34,792
NASDAQ
REGN
Regeneron Pharmaceuticals
STAHL NEIL
/
officer: EVP Research and Development
12/16/2024
Sell
$730.81
304
$222K
48,829
NASDAQ
REGN
Regeneron Pharmaceuticals
Pitofsky Jason
/
officer: VP Controller
12/16/2024
Sell
$730.81
298
$218K
4,664
NASDAQ
REGN
Regeneron Pharmaceuticals
MURPHY ANDREW J
/
officer: EVP Research
12/16/2024
Sell
$730.81
1,054
$770K
49,074
NASDAQ
REGN
Regeneron Pharmaceuticals
McCourt Marion
/
officer: EVP Commercial
12/16/2024
Sell
$730.81
759
$555K
14,230
NASDAQ
REGN
Regeneron Pharmaceuticals
LAROSA JOSEPH J
/
officer: EVP General Counsel and Secret
12/16/2024
Sell
$730.81
702
$513K
30,075
NASDAQ
REGN
Regeneron Pharmaceuticals
Fenimore Christopher R.
/
officer: SVP Finance & CFO
12/16/2024
Sell
$730.81
491
$359K
16,265
NASDAQ
REGN
Regeneron Pharmaceuticals
Pitofsky Jason
/
officer: VP Controller
12/09/2024
Sell
$787.00
149
$117K
4,962
NASDAQ
REGN
Regeneron Pharmaceuticals
Pitofsky Jason
/
officer: VP Controller
12/06/2024
Buy
$771.64
3,236
$2.497M
3,236
NASDAQ
REGN
Regeneron Pharmaceuticals
Fenimore Christopher R.
/
officer: SVP Finance & CFO
12/09/2024
Sell
$787.00
1,140
$897K
16,756
NASDAQ
REGN
Regeneron Pharmaceuticals
Fenimore Christopher R.
/
officer: SVP Finance & CFO
12/06/2024
Buy
$771.64
9,979
$7.700M
9,979
NASDAQ
REGN
Regeneron Pharmaceuticals
STAHL NEIL
/
officer: EVP Research and Development
12/09/2024
Sell
$787.00
466
$367K
49,133
NASDAQ
REGN
Regeneron Pharmaceuticals
Van Plew Daniel P
/
officer: EVP & General Mgr, Industrial
12/09/2024
Sell
$787.00
492
$387K
35,761
NASDAQ
REGN
Regeneron Pharmaceuticals
Van Plew Daniel P
/
officer: EVP & General Mgr, Industrial
12/06/2024
Buy
$771.64
13,472
$10.396M
13,472
NASDAQ
REGN
Regeneron Pharmaceuticals
MURPHY ANDREW J
/
officer: EVP Research
12/09/2024
Sell
$787.00
492
$387K
50,128
NASDAQ
REGN
Regeneron Pharmaceuticals
MURPHY ANDREW J
/
officer: EVP Research
12/06/2024
Buy
$771.64
13,472
$10.396M
13,472
NASDAQ
REGN
Regeneron Pharmaceuticals
McCourt Marion
/
officer: EVP Commercial
12/09/2024
Sell
$787.00
274
$216K
14,989
NASDAQ
REGN
Regeneron Pharmaceuticals
McCourt Marion
/
officer: EVP Commercial
12/06/2024
Buy
$771.64
8,981
$6.930M
8,981
NASDAQ
REGN
Regeneron Pharmaceuticals
LAROSA JOSEPH J
/
officer: EVP General Counsel and Secret
12/09/2024
Sell
$787.00
492
$387K
30,777
NASDAQ
REGN
Regeneron Pharmaceuticals
LAROSA JOSEPH J
/
officer: EVP General Counsel and Secret
12/06/2024
Buy
$771.64
8,981
$6.930M
8,981
NASDAQ
REGN
Regeneron Pharmaceuticals
McCourt Marion
/
officer: EVP Commercial
11/01/2024
Buy
$381.40
1,000
$381K
13,931
NASDAQ
REGN
Regeneron Pharmaceuticals
McCourt Marion
/
officer: EVP Commercial
11/01/2024
Sell
$844.61
1,000
$845K
12,931
NASDAQ
REGN
Regeneron Pharmaceuticals
McCourt Marion
/
officer: EVP Commercial
11/01/2024
Sell
$381.40
1,000
$381K
6,000
Research Tools
Stock Screener
FDA Catalyst Calendar
Insider Transactions
Life Science Stock Lists
All Life Science Stocks
News & Announcements
All Life Science News
Clinical Trial News
Company FDA Updates
Mergers & Acquisitions
Search News & Events
Popular Topics
Top Stocks in 2025
Big Pharma Stocks
Artificial Intelligence
Obesity Drugs
Psychedelic Stocks
Miscellaneous
Free Daily Newsletter
Follow Us On X
Advertise
Privacy Policy
Disclaimer
Tweet
Share
Share
Share
Share
Sign Up To Get Daily Life Science Stock News
Register
or
Login
to Access Entire Platform.